A New Jersey pharmaceutical company is recalling some lots of its lidocaine hydrochloride topical solution because it may be “super potent.” According to an announcement with the U.S. Food and Drug ...
RECALLED label. Do not use. Used in recall story. The recalled lot of Lidocaine HCl Topical Solution 4% (40mg/mL) was distributed at the wholesale and retail distribution levels. Teligent Pharma is ...
About 50,000 containers of a pain-relief ointment sold nationwide have been recalled due to packaging that fails to meet ...
While still trying to address an FDA warning letter issued nearly two years ago, New Jersey pharma Teligent says it’s yanking a lot of its topical pain numbing treatment after testing found the med to ...
Please provide your email address to receive an email when new articles are posted on . Tylenol Precise is made with lidocaine 4% and does not require a prescription. The product is made to appease 40 ...
One hundred and five patients scheduled for cataract surgery with topical anaesthesia were randomly allocated into 3 groups of 35 patients each to receive eye drops of lidocaine 2%, levobupivacaine ...
In a recent preprint study posted in Preprints with The Lancet, a team of researchers investigated the efficacy of lidocaine for the treatment of neck pain and assessed the need for additional ...
Scilex Holding Company, an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, ...
More frequent meetings or written communication with the FDA to discuss the SP-103 development plan and ensure collection of appropriate data needed to support drug approval. Eligibility for ...
Teligent Pharma has voluntarily recalled two lots of Lidocaine HCl Topical Solution USP 4% because testing found it to be “super potent.” People could be using a higher than intended dose of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results